Edesa Biotech

+$0.04 (+2.30%) As of 1:22 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Edesa Biotech and other ETFs, options, and stocks.

About EDSA

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its product candidate, EB01 is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis, a common, potentially debilitating condition and occupational illness.

CEO
Pardeep Nijhawan
Employees
16
Headquarters
Markham, Ontario
Founded
2007

EDSA Key Statistics

Market cap
26.90M
Price-Earnings ratio
—
Dividend yield
—
Average volume
59.49K
High today
$1.83
Low today
$1.70
Open price
$1.74
Volume
63.05K
52 Week high
$12.00
52 Week low
$1.70

EDSA News

BenzingaMay 24

Edesa Biotech Adds Mechanically Ventilated Patients To Late-Stage COVID-19 Study

by Edesa Biotech Inc EDSA has initiated enrollment for the second cohort of patients for the Phase 3 part of a Phase 2/3 study of the company's critical care d

EDSA Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
-$0.33 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure